Λιανίδου Εύη
Dr. Evi Lianidou is Professor of Analytical Chemistry and Clinical Chemistry at the Department of Chemistry, University of Athens, Greece. Dr Lianidou has established a Molecular Diagnostics Laboratory focused on Liquid Biopsy at the Department of Chemistry since 1998 (http://en.actc-lab.chem.uoa.gr/). Her lab is specializing in the Analysis of Circulating Tumor Cells (ACTC), and has access to many patient samples through extensive clinical collaborations. Her main research interests are on the development and clinical evaluation of: a) single-plex and multiplex quantitative RT-qPCR assays for the detection and molecular characterization of CTCs, b) multiplex assays for gene expression in CTCs based on the liquid bead array (LUMINEX platform), c) DNA methylation assays in CTCs and ctDNA, d) highly sensitive assays for mutation analysis in CTCs and in ctDNA, and e) evaluation of circulating miRNAs as tumor biomarkers in plasma.
Dr. Lianidou has 137 publications (https://www.ncbi.nlm.nih.gov/pubmed/?term=lianidou) and has organized together with Prof K. Pantel four international meetings on liquid biopsy: a) the 7th International Symposium on Minimal Residual Disease in Athens, (http://ismrc2009.chem.uoa.gr) , b) the 1st “Advances in Circulating Tumor Cells: From Basic Research to Clinical Practice” (www.actc2012.org), c) the 2nd ACTC meeting, (October 8th-11th, 2014), in Crete, Greece (www.actc2014.org), d) the 3rd ACTC meeting, (October 4th-7th, 2017), in Rhodes, Greece (www.actc2017.org) and the 4th ACTC meeting in Corfu, Greece (https://actc2019.org). Prof Lianidou is PI in the European TRANSCAN group “CTC-SCAN” and in the EU IMI Network Project “CANCER-ID” (www.cancer-id.eu) and a member of the European Liquid Biopsy Society (ELBS). Dr Lianidou serves on the Editorial Boards of many international journals including Clin Chemistry, Clin. Cancer Res, Breast Cancer Res, Cancer Res, Oncotarget, and many others.
Dr. Lianidou served International Federation of Clinical Chemistry (IFCC) as an elected member and Chair of the Committee for Clinical Molecular Biology Curriculum (2014-2019, (http://www.ifcc.org/ifcc-education-division/emd-committees/c-cmbc/) and is since 2020 an elected member of the IFCC Committee on Proficiency Testing (C-PT). She is also an elected member of the European Association of Cancer Research (EACR) board.
